Sign in →

Test ID BPAB Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)


Specimen Required


Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Submission container/tube: Plastic vial

Specimen Volume: 1 mL Serum

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Reporting Name

BP 180 and 230, Serum

Specimen Type

Serum Red

Specimen Stability Information

Specimen Type Temperature Time
Serum Red Refrigerated (preferred) 14 days
  Frozen  30 days
  Ambient  14 days

Report Available

1 to 5 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

LOINC Code Information

Test ID Test Order Name Order LOINC Value
BPAB BP 180 and 230, Serum 92671-7

 

Result ID Test Result Name Result LOINC Value
606816 BP 180, S 53842-1
606817 BP 230, S 53843-9

Useful For

Initial screening test in the diagnosis of bullous pemphigoid and its variants

 

Complementing the standard serum test of indirect immunofluorescence utilizing primate esophagus substrate and primate salt-split skin substrate (CIFS / Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum)

Testing Algorithm

For information see Autoimmune Blistering Disease Diagnostic Algorithm.

Day(s) Performed

Varies

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

83516 x 2

Specimen Minimum Volume

Serum 0.5 mL

Reference Values

Bullous Pemphigoid 180:

<20 RU/mL (Negative)

≥20 RU/mL (Positive)

 

Bullous Pemphigoid 230:

<20 RU/mL (Negative)

≥20 RU/mL (Positive)